4521 — Kaken Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Annual balance sheet for Kaken Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	—	—	—	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	74,624	74,260	65,324	70,085	50,705
Net Total Accounts Receivable
Net Total Receivables	20,260	19,268	23,744	21,178	22,748
Total Inventory
Total Other Current Assets
Total Current Assets	110,613	109,903	106,974	111,377	94,051
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	25,734	25,498	25,355	27,629	27,134
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	165,181	166,328	171,623	190,422	178,217
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19,049	20,838	19,024	30,354	20,803
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	27,434	30,070	27,868	37,788	30,598
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	137,747	136,258	143,755	152,634	147,619
Total Liabilities & Shareholders' Equity	165,181	166,328	171,623	190,422	178,217
Total Common Shares Outstanding